XML 11 R5.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 150,724 $ 7 $ 490,874 $ (77) $ (340,080)
Beginning Balance, Shares at Dec. 31, 2023   67,891,311      
Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options (169)   (169)    
Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options, shares   184,998      
Issuance of common stock from at-the-market sales agreements, Shares   139,462      
Issuance of common stock from at-the-market sales agreement 213   213    
Stock-based compensation expense 3,081   3,081    
Other comprehensive income (loss) (10)     (10)  
Net loss (30,804)       (30,804)
Ending Balance at Mar. 31, 2024 123,035 $ 7 493,999 (87) (370,884)
Ending Balance, Shares at Mar. 31, 2024   68,215,771      
Beginning Balance at Dec. 31, 2024 $ 96,664 $ 13 553,623 22 (456,994)
Beginning Balance, Shares at Dec. 31, 2024 124,776,152 124,776,152      
Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options $ (55)   (55)    
Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes, and exercise of stock options, shares   75,395      
Issuance costs for private placement 12   12    
Stock-based compensation expense 1,933   1,933    
Other comprehensive income (loss) 1     1  
Net loss (32,486)       (32,486)
Ending Balance at Mar. 31, 2025 $ 66,069 $ 13 $ 555,513 $ 23 $ (489,480)
Ending Balance, Shares at Mar. 31, 2025 124,851,547 124,851,547